Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Jan 04, 2019 9:39am
33 Views
Post# 29185592

RE:RE:Last 5 minutes

RE:RE:Last 5 minutesThey have made it known that thier desire it to find a partner.  They only have 3.5 million shares outstanding so they are certainly not quick to issue shares to raise money.  I think they will be focusing on findng a new partner over the next month and if they are not able to find somethign that gives sharholders the value they believe the company is worth then they will have to raise money.  I loved the structure of the most recent convertable debts.  I think anything they do to raise money will be similar and a short term fix because they are not going to want to issue shares at $4 because they would dilute value too much, I think they would sooner do somethign to get through the next 6 months and wait for some more positive progress on one or more of the drug trails and hope for a SP boast before issueing any more shares. 
<< Previous
Bullboard Posts
Next >>